EPO and pure red-cell aplasia: The co-occurrence of ‘ESAs’, ‘anti-erythropoietin antibody’ and ‘pure red cell aplasia (PRCA)’ in the keyword cluster #7 analysis indicates antibody-mediated ESA risk, although this rare but serious complication is mainly caused by subcutaneous ESA administration [65].